Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
J Small Anim Pract ; 65(2): 144-148, 2024 02.
Article in English | MEDLINE | ID: mdl-37559209

ABSTRACT

A 15-year-old spayed female mongrel presented with anorexia and an abdominal mass. The mass originated from the gall bladder and was surgically resected along with divisionectomy of the central hepatic division. Paroxysmal hypertension and tachycardia were noted during manipulation of the mass. Following resection, arterial blood pressure decreased significantly. Histopathological analysis confirmed a diagnosis of neuroendocrine neoplasm. Immunohistochemical staining for synaptophysin and chromogranin A yielded diffuse and strong positive results, while gastrin was positive in only 10% of the cells. The preoperative elevated concentrations of catecholamine in the urinalysis showed a marked decrease after surgery. Based on these findings, the tumour was diagnosed as a functional paraganglioma of the gall bladder. The patient has undergone regular thoracic radiographs and ultrasound examinations and, until 431 days after surgery, has shown no signs of metastases or recurrences. Based on our literature search, we report the first case of functional paraganglioma of the gall bladder in a dog.


Subject(s)
Dog Diseases , Hypertensive Crisis , Paraganglioma , Urinary Bladder Neoplasms , Humans , Dogs , Female , Animals , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/pathology , Urinary Bladder Neoplasms/surgery , Urinary Bladder Neoplasms/veterinary , Hypertensive Crisis/veterinary , Gallbladder/pathology , Paraganglioma/complications , Paraganglioma/diagnosis , Paraganglioma/surgery , Paraganglioma/veterinary , Catecholamines , Dog Diseases/diagnosis , Dog Diseases/surgery
2.
Pol J Vet Sci ; 25(2): 223-229, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35861958

ABSTRACT

Gallbladder mucocele (GM) is a common extrahepatic biliary disease recognized in dogs and is defined as the expansion and extension of the gallbladder by an accumulation of semi-solid bile or bile acid. Histopathological diagnosis of necrotizing cholecystitis and transmural coagulative necrosis of the gallbladder wall shows poor prognosis. Conversely, histopathological diagnosis with partial necrotic findings is often achieved. We hypothesized that histopathological partial necrosis of the gallbladder wall is the primary lesion of necrotic cholecystitis or transmural ischemic necrosis. Therefore, we investigated the relationship between histopathological necrosis/ partial necrosis findings and their clinical conditions. We retrospectively analyzed 55 dogs diagnosed with GM that had undergone cholecystectomy at the Yamaguchi University Animal Medical Center. The group with histopathological necrosis/partial necrosis of the gallbladder wall showed elevated levels of preoperative white blood cells, alanine transaminase, alkaline phosphatase, γ-glutamyltransferase, total bilirubin, and C-reactive protein compared to the non-necrotic group. Partial necrosis of the gallbladder wall may affect the progression of the disease and hematological abnormalities. Additionally, all death cases until 2 weeks were included in the histopathological necrosis/partial necrosis group. In this study, we found that poor prognosis factors were associated with partial necrosis of the gallbladder wall. Furthermore, these cases of partial necrosis showed elevated levels of blood test parameters. These results suggest that necrosis of the gallbladder wall is associated with poor prognosis and poor pathophysiological conditions.


Subject(s)
Cholecystitis , Dog Diseases , Gallbladder Diseases , Mucocele , Animals , Cholecystitis/complications , Cholecystitis/veterinary , Dog Diseases/pathology , Dogs , Gallbladder Diseases/complications , Gallbladder Diseases/surgery , Gallbladder Diseases/veterinary , Humans , Mucocele/complications , Mucocele/pathology , Mucocele/veterinary , Necrosis/complications , Necrosis/veterinary , Retrospective Studies
3.
Vet Comp Oncol ; 16(2): 229-238, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29076241

ABSTRACT

Oncolytic virotherapy is a novel treatment involving replication-competent virus in the elimination of cancer. We have previously reported the oncolytic effects of reovirus in various canine cancer cell lines. This study aims to establish the safety profile of reovirus in dogs with spontaneously occurring tumours and to determine a recommended dosing regimen. Nineteen dogs with various tumours, mostly of advanced stages, were treated with reovirus, ranging from 1.0 × 108 to 5.0 × 109 TCID50 given as intratumour injection (IT) or intravenous infusion (IV) daily for up to 5 consecutive days in 1 or multiple treatment cycles. Adverse events (AEs) were graded according to the Veterinary Cooperative Oncology Group- Common Terminology Criteria for Adverse Events (VCOG-CTCAE) v1.1 guidelines. Viral shedding, neutralizing anti-reovirus antibody (NARA) production and immunohistochemical (IHC) detection of reovirus protein in the tumours were also assessed. AE was not observed in most dogs and events were limited to Grade I or II fever, vomiting, diarrhoea and inflammation of the injected tumour. No infectious virus was shed and all dogs had elevated NARA levels post-treatment. Although IHC results were only available in 6 dogs, 4 were detected positive for reovirus protein. In conclusion, reovirus is well-tolerated and can be given safely to tumour-bearing dogs according to the dosing regimen used in this study without significant concerns of viral shedding. Reovirus is also potentially effective in various types of canine tumours.


Subject(s)
Dog Diseases/drug therapy , Dog Diseases/immunology , Neoplasms/veterinary , Oncolytic Virotherapy/veterinary , Oncolytic Viruses/immunology , Reoviridae/immunology , Animals , Antibodies, Neutralizing/blood , Antineoplastic Agents/immunology , Antineoplastic Agents/pharmacology , Dogs , Female , Japan , Male , Neoplasms/drug therapy , Neoplasms/immunology , Oncolytic Virotherapy/methods , Pilot Projects , Polymerase Chain Reaction , Schools, Veterinary , Treatment Outcome , Virus Shedding
4.
J Vet Intern Med ; 24(5): 1013-9, 2010.
Article in English | MEDLINE | ID: mdl-20695991

ABSTRACT

BACKGROUND: GM2 gangliosidosis variant 0 (human Sandhoff disease) is a lysosomal storage disorder caused by deficiencies of acid ß-hexosaminidase (Hex) A and Hex B because of an abnormality of the ß-subunit, a common component in these enzyme molecules, which is coded by the HEXB gene. OBJECTIVE: To describe the clinical, pathological, biochemical, and magnetic resonance imaging (MRI) findings of Sandhoff-like disease identified in a family of Toy Poodles. ANIMALS: Three red-haired Toy Poodles demonstrated clinical signs including motor disorders and tremor starting between 9 and 12 months of age. The animals finally died of neurological deterioration between 18 and 23 months of age. There were some lymphocytes with abnormal cytoplasmic vacuoles detected. METHODS: Observational case study. RESULTS: The common MRI finding was diffuse T2-hyperintensity of the subcortical white matter in the cerebrum. Bilateral T2-hyperintensity and T1-hypointensity in the nucleus caudatus, and atrophic findings of the cerebrum and cerebellum, were observed in a dog in the late stage. Histopathologically, swollen neurons with pale to eosinophilic granular materials in the cytoplasm were observed throughout the central nervous system. Biochemically, GM2 ganglioside had accumulated in the brain, and Hex A and Hex B were deficient in the brain and liver. Pedigree analysis demonstrated that the 3 affected dogs were from the same family line. CONCLUSIONS AND CLINICAL IMPORTANCE: The Sandhoff-like disease observed in this family of Toy Poodles is the 2nd occurrence of the canine form of this disease and the 1st report of its identification in a family of dogs.


Subject(s)
Dog Diseases/genetics , Gangliosidoses, GM2/veterinary , Animals , Dog Diseases/pathology , Dogs , Fatal Outcome , Female , Gangliosidoses, GM2/genetics , Gangliosidoses, GM2/pathology , Male , Pedigree
6.
Res Vet Sci ; 78(3): 217-24, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15766940

ABSTRACT

New multidrug resistant cell lines developed from the canine B cell lymphoma cell line (GL-1) were characterized in terms of chemosensitivity to some antineoplastics and P-glycoprotein (Pgp) expression. GL-1 was continuously exposed to a culture medium containing gradually increasing levels of doxorubicin and the cells that could grow in the presence of doxorubicin were obtained. Chemosensitivity of these cells to various antineoplastics were investigated with or without verapamil, which reversed Pgp-mediated drug resistance. The expression of Pgp on the cells was also examined by Western blot analysis. As a result, three kinds of resistant cell lines, designated as GL-DOX60, 300, and 4000 were obtained. These cell lines showed stable proliferation in the medium containing 60, 300, and 4000 ng/ml, respectively. These cells were much more resistant to vincristine than doxorubicin. This resistance was strongly reversed by the presence of verapamil. On the other hand, cisplatin was effective enough in killing these derived cells. In the Western Blot analysis, some bands that reacted to the anti-human Pgp monoclonal antibodies were observed in GL-DOX4000. The cells derived from GL-1 have multidrug resistance potential mediated by canine Pgp. The cells produced in this experimental trial are considered to be useful models for various investigations on canine multidrug resistance.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism , Antineoplastic Agents/pharmacology , Drug Resistance, Neoplasm , Lymphoma/veterinary , Animals , Cell Line, Tumor/drug effects , Cisplatin/pharmacology , Dogs , Doxorubicin/pharmacology , Drug Resistance, Multiple , Gene Expression Regulation, Neoplastic , Inhibitory Concentration 50 , Lymphoma/drug therapy , Verapamil/pharmacology , Vincristine/pharmacology
8.
Vet Comp Oncol ; 3(4): 203-10, 2005 Dec.
Article in English | MEDLINE | ID: mdl-19754775

ABSTRACT

Abstract In human and canine cancers, the inactivation of p53 protein as well as p53 gene mutation and MDM2 overexpression result in centrosome amplification that in turn contributes to chromosomal instability. To explore the usefulness of the detection of centrosome amplification as a surrogate marker of dysfunction in the p53 pathway, we systematically analysed centrosome amplification, p53 overexpression, p53 gene mutation and MDM2 overexpression in canine tumours. Centrosome amplification was detected in 16 of 51 (31%) naturally developing tumours in dogs. All the tumour specimens with aberrations in the p53 pathway, including p53 overexpression, p53 gene mutation or MDM2 overexpression, showed centrosome amplification, suggesting that the detection of centrosome amplification could serve as a preliminary surrogate marker of dysfunction in the p53 pathway.

9.
J Vet Med A Physiol Pathol Clin Med ; 49(4): 169-72, 2002 May.
Article in English | MEDLINE | ID: mdl-12069256

ABSTRACT

The purpose of this study was to evaluate the effects of the administration of an alpha2-adrenoceptor agonist alone and in combination with other derivatives on brain wave activity. In addition, the diagnostic values of the electroencephalogram (EEG) for judging the depth of the balanced anaesthesia with an alpha2-adrenoceptor agonist was evaluated. The treatments comprised 20 microg/kg medetomidine (Me-20), 80 microg/kg medetomidine (Me-80), 20 microg/kg medetomidine and 0.5 mg/kg midazolam (Me-Mi) administered intramuscularly, and 20 microg/kg medetomidine with 0.5 mg/kg midazolam and 0.1 mg/kg butorphanol (Me-Mi-Bu). The EEG was recorded continuously at pre-administration, and at 7, 10, 20, 30, 45 and 60 min after administration. The recorded data were analysed by separating the power spectrum into 1-3, 4-7, 8-13 and 14-30 Hz bands. Spectral-edge analysis was used to calculate the spectral edge frequency 90 (SEF90) and the median edge frequency (MEF). Time-related changes in power spectrum analysis showed a significant increase in the Me-80 group in the 1-3 Hz band. The power for 1-3 Hz in the Me-80 group was significantly higher than in all the other groups. In the 14-30 Hz band, there was a significant reduction of power in all groups following administration of the agents. The SEF90 frequencies were significantly reduced in all groups except for the Me-20 group after administration of the agents. The SEF90 frequencies in the Me-20, Me-Mi and Me-Mi-Bu were all significantly higher than those in the Me-80 group. However, there was no significant difference between the Me-20, Me-Mi and Me-Mi-Bu groups in any analyses. Our results demonstrated that the changes in quantitative EEG made by the Me-Mi-Bu and Me-Mi groups were similar to those made by Me-20 groups. Present results suggest that the EEG should be interpreted with caution in assessing the anaesthetic level in balanced anaesthesia in dogs.


Subject(s)
Adrenergic alpha-Agonists/pharmacology , Analgesics, Opioid/pharmacology , Brain/drug effects , Butorphanol/pharmacology , Dogs/physiology , Hypnotics and Sedatives/pharmacology , Medetomidine/pharmacology , Midazolam/pharmacology , Anesthesia/veterinary , Animals , Brain/physiology , Dose-Response Relationship, Drug , Electroencephalography/drug effects , Electroencephalography/methods , Electroencephalography/veterinary , Female , Injections, Intramuscular/veterinary , Kinetics , Male
10.
J Vet Med A Physiol Pathol Clin Med ; 49(1): 27-31, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11913822

ABSTRACT

Using reverse transcription-polymerase chain reaction (RT-PCR) and semi-quantitative PCR techniques, mRNA expression for canine interferon (IFN)-gamma, interleukin (IL)-4, IL-5 and IL-10 in freshly isolated peripheral blood mononuclear cells (PBMCs) was examined in dogs with or without atopic dermatitis (AD). The expression of IFN-gamma mRNA in dogs with AD was lower than that in dogs without AD (healthy control). The expression of IL-5 mRNA was higher in dogs with AD than in control dogs, but there were no significant differences in IL-4 mRNA and IL-10 mRNA expression between the groups. The number of circulating eosinophils was higher in dogs with AD than in control dogs, although eosinophilia was found in only one dog with AD. These results suggest that there is a tendency for the PBMCs of atopic dogs to express a type 2 cytokine pattern that is similar to the pattern observed in human AD patients.


Subject(s)
Cytokines/metabolism , Dermatitis, Atopic/veterinary , Dog Diseases/immunology , Leukocytes, Mononuclear/metabolism , RNA, Messenger/blood , Animals , Case-Control Studies , Cytokines/genetics , DNA Primers , Dermatitis, Atopic/immunology , Dog Diseases/blood , Dogs , Female , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-4/metabolism , Male , Polymerase Chain Reaction/veterinary , Reverse Transcriptase Polymerase Chain Reaction/veterinary
11.
Bioorg Med Chem ; 9(7): 1747-52, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11425576

ABSTRACT

Distinct biological properties of the ortho-carboranyl (1,2-dicarba-closo-dodecaboranyl) glycosides 1, 2 and 3 were evaluated to estimate the suitability of these compounds for cancer treatment by boron neutron capture therapy. The boron uptake into B16-Melanoma cells was significantly higher by incubating the cells with aqueous solutions of carboranyl glucoside 1 (11.2 ppm after 3h), lactoside 2 (13.2 ppm after 12h) and maltoside 3 (20.0 ppm after 24h) compared with solutions of clinically used p-boronophenylalanine (BPA) 5 (3.1 ppm after 24h). Carboranyl maltoside 3 was more effective than boron-10 enriched 5 in killing C-6 rat glioma cells by incubating the cells with the compound and subsequent treatment with thermal neutrons. 3 was also administrated iv, in concentrations of 25 mg boron/kg body weight to rats bearing brain tumors. After a period of 4h after administration the concentration of boron in the tumor tissue was 3.0 ppm.


Subject(s)
Boron Neutron Capture Therapy , Brain Neoplasms/drug therapy , Glioma/drug therapy , Glycosides/therapeutic use , Melanoma/drug therapy , Animals , Brain Neoplasms/pathology , Glioma/pathology , Glycosides/chemistry , Male , Melanoma/pathology , Rats , Rats, Wistar
12.
Chembiochem ; 2(5): 326-34, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11828461

ABSTRACT

Boron neutron capture therapy is a special type of radiotherapy for the treatment of cancer by using boron compounds. Problems often arise from the low water solubility of these compounds, their unselective uptake into the cancer cells, and their toxicity. Here we describe the novel water-soluble ortho-carboranyl bisglycosides 7 and 10 containing either lactose or glucose and the mixed bisglycosides 1 and 28 containing glucose, mannose, and galactose. The carboranyl bisglycosides show almost no toxicity toward bronchial carcinoma cells of line A549 up to a concentration of 0.50 mM. As anticipated, these compounds exhibit nearly no uptake into C6 glioma cells; they can therefore be used for a selective delivery into malignant cells by using conjugates of glycohydrolases and monoclonal antibodies which bind to tumor-associated antigens, since by enzymatic hydrolysis the bisglycosides are transformed into lipophilic compounds.


Subject(s)
Antineoplastic Agents/chemical synthesis , Boron Compounds/chemical synthesis , Boron Neutron Capture Therapy/methods , Disaccharides/chemical synthesis , Antineoplastic Agents/pharmacokinetics , Antineoplastic Agents/toxicity , Boron Compounds/pharmacokinetics , Boron Compounds/toxicity , Disaccharides/pharmacokinetics , Disaccharides/toxicity , Drug Delivery Systems , Glycosides/chemical synthesis , Glycosides/pharmacokinetics , Glycosides/toxicity , Humans , Molecular Structure , Solubility , Structure-Activity Relationship , Tumor Cells, Cultured
13.
J Vet Med Sci ; 63(12): 1331-4, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11789613

ABSTRACT

A 3-month-old male Japanese cat with feline parvovirus infection, showing central and cervical nerve abnormalities, was diagnosed as hydrocephalus and syringomyelia by use of magnetic resonance imaging (MRI). The cat was maintained clinically by medical treatment even though he could not stand. The MRI scans obtained about 5 months later showed that the ventricles had increased in size and the cervical syrinx had extended into the thoracic spinal cord. Ventriculoperitoneal (VP) shunt was performed. One week after surgery, neurological conditions had improved. At the postoperative MR images, the ventricles had decreased in size and the syrinx in the cervical and thoracic spinal cord could no longer be seen. The cat was still alive and was able to walk well.


Subject(s)
Cat Diseases/diagnosis , Hydrocephalus/veterinary , Syringomyelia/veterinary , Ventriculoperitoneal Shunt/veterinary , Animals , Cat Diseases/therapy , Cats , Diuretics/therapeutic use , Furosemide/therapeutic use , Hydrocephalus/diagnosis , Hydrocephalus/therapy , Magnetic Resonance Imaging/veterinary , Male , Syringomyelia/diagnosis , Syringomyelia/therapy
15.
J Vet Med Sci ; 62(1): 81-4, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10676895

ABSTRACT

In this study antemortem evaluation of equine flexor tendons--the superficial digital flexor tendon and the deep digital flexor tendon--using magnetic resonance (MR) images was performed. Postmortem flexor tendons were used to prepare the slice positions, coil and body positions for MR imaging. It was possible by this method to take antemortem MR images of equine limbs that distinguished features as well as postmortem images described in previous studies. The total time of antemortem scanning was about 40 min. This study is the first to report antemortem MR images in horses.


Subject(s)
Horse Diseases/diagnosis , Magnetic Resonance Imaging/veterinary , Tendinopathy/veterinary , Tendons/pathology , Anesthesia, Inhalation/veterinary , Animals , Female , Forelimb/pathology , Hindlimb/pathology , Horses , Lameness, Animal/diagnosis , Male , Tendinopathy/diagnosis
16.
Res Vet Sci ; 66(3): 169-74, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10333454

ABSTRACT

Six anti-tumour drugs namely; doxorubicin, mitoxantrone, vincristine, cisplatin, recombinant human tumour necrosis factor alpha (rh-TNFalpha) and recombinant feline interferon gamma (rf-IFNgamma) were singly evaluated for their anti-proliferative effects on two feline cell lines (FRM and NAC) derived from mammary adenocarcinoma and grown as monolayers. We obtained concentration response curves that enabled the determination of the concentration inhibiting growth by 50 per cent (IC50) for the chemotherapeutic agents with VCR exhibiting exponential-plateau curves. Differences in anti-proliferative effects of drugs to a given cell line and between the cell lines were also observed. NAC cells were relatively more resistant compared with FRM cells. The relative resistances for NAC cells were 4.19, 12.96, 0.05 and 2.10-fold to doxorubicin, mitoxantrone, vincristine and cisplatin, respectively. FRM cells were more resistant to VCR at lower concentrations compared with NAC cells. The cells appeared, at least in vitro, least sensitive to rh-TNFalpha and rf-IFNgamma. rh-TNFalpha and rf-IFNgamma were 23 and 29 per cent inhibitory to FRM cells and only 13 and 15 per cent inhibitory to NAC cells, respectively.


Subject(s)
Antineoplastic Agents/pharmacology , Cat Diseases/pathology , Cisplatin/pharmacology , Interferon-gamma/pharmacology , Mammary Neoplasms, Animal/pathology , Mitoxantrone/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Animals , Antineoplastic Agents/administration & dosage , Cats , Cell Division/drug effects , Cisplatin/administration & dosage , Dose-Response Relationship, Drug , Female , Humans , Interferon-gamma/administration & dosage , Mitoxantrone/administration & dosage , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/administration & dosage , Vincristine/pharmacology
17.
J Vet Med Sci ; 60(8): 931-5, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9764406

ABSTRACT

A new cell line designated FRM was established from pleural effusion of a 13-year-old female cat with mammary adenocarcinoma. The cell line exhibited irregular round and polygonal shaped epithelial cells and demonstrated cell growth in a monolayer fashion with a doubling time of 22.4 hr. It possessed a modal chromosome number of 79. The immortality of this cell line was demonstrated using the TRAP assay which revealed a high telomeric activity of these cells. Scatchard analysis revealed quite low levels of estrogen receptors in both tumor mass produced in nude mice and FRM cells. Subcutaneous transplantation of the cells produced localized palpable masses in athymic nude mice within two weeks. This cell line may provide a good model for in vivo and in vitro studies on feline mammary tumors.


Subject(s)
Adenocarcinoma/veterinary , Cat Diseases/pathology , Mammary Neoplasms, Animal/pathology , Adenocarcinoma/pathology , Animals , Cats , Cell Culture Techniques/methods , Cell Division , Cell Line , Female , Kinetics , Male , Mice , Mice, Nude , Pleural Effusion/pathology , Pleural Effusion/veterinary , Telomerase/metabolism , Transplantation, Heterologous , Tumor Cells, Cultured
18.
Vet Radiol Ultrasound ; 39(3): 185-9, 1998.
Article in English | MEDLINE | ID: mdl-9634184

ABSTRACT

Eighteen healthy Beagle-type dogs were studied using magnetic resonance (MR) imaging from a few days after birth up to 7 months of age. We evaluated the onset of lateral ventricular expansion, the developmental change of lateral ventricular volume and the ratio of the largest to the smallest lateral ventricular volume. The onset of lateral ventricular expansion was defined as the day that the expansion by cerebrospinal fluid (CSF) was first visible in unilateral or bilateral lateral ventricles on the transverse images at the level of the intraventricular foramen. It was found that the expansion of lateral ventricles were first detectable at 3-4 weeks. Lateral ventricular volume ratio varied most from the onset of lateral ventricular expansion to 75 days of age and stabilized after that, although absolute brain and lateral ventricular volumes continued to increase.


Subject(s)
Cerebral Ventricles/growth & development , Dogs/anatomy & histology , Magnetic Resonance Imaging , Animals , Cerebral Ventricles/anatomy & histology , Female , Male , Reference Values
19.
Vet Radiol Ultrasound ; 38(6): 430-3, 1997.
Article in English | MEDLINE | ID: mdl-9402708

ABSTRACT

Magnetic resonance (MR) imaging was performed on 21 presumed normal Beagle-type dogs. The size and symmetry of their lateral ventricles were evaluated and dogs were categorized on the basis of the percentage of their ventricular height (Vh) to brain height (Bh) and the ratio of the largest to the smallest ventricular area (rVA). Eleven dogs had lateral ventricles classified as normal sized (0-14% Vh/Bh) while 10 of 21 dogs had moderate enlargement (15-25% Vh/Bh) of one or both lateral ventricles. None of the dogs had severe lateral ventricular enlargement. Degree of asymmetry was also arbitrarily categorized on basis of rVA as normal to minimal (rVA < 1.5), mild (1.5 < rVA < 2.0), or severe (2.0 < rVA). Of the dogs having normal-sized lateral ventricles, six of eleven had symmetric, three of eleven had mildly asymmetric and two of eleven had severely asymmetric lateral ventricles. Of the dogs having at least one moderately enlarged lateral ventricles, five of ten had symmetric lateral ventricles, and two of ten had mild asymmetry and three of ten had severe asymmetry. Gender and body weight had no statistical relationship to lateral ventricle symmetry. Clinically insignificant ventricular enlargement and asymmetry was common in this group of Beagle dogs.


Subject(s)
Cerebral Ventricles/anatomy & histology , Dogs/anatomy & histology , Magnetic Resonance Imaging/veterinary , Animals , Brain/anatomy & histology , Female , Male
20.
Vet Radiol Ultrasound ; 38(6): 444-7, 1997.
Article in English | MEDLINE | ID: mdl-9402711

ABSTRACT

The study was carried out to evaluate the applicability of magnetic resonance imaging (MRI) in detecting tumors in the abdomen of the dog. Abdominal ultrasound and MRI were performed on 8 dogs having a mass lesion on abdominal radiography. MR images were obtained in the transverse, sagittal and dorsal planes using T1- and T2-weighted spin echo pulse sequences. There was good visual correlation of the lesion site by MRI and ultrasonography (US).


Subject(s)
Abdominal Neoplasms/diagnosis , Abdominal Neoplasms/veterinary , Dog Diseases/diagnosis , Magnetic Resonance Imaging/instrumentation , Abdomen/diagnostic imaging , Abdomen/pathology , Animals , Dog Diseases/diagnostic imaging , Dogs , Evaluation Studies as Topic , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...